INVESTER I GUANGDONG TRUE HEALTH MEDICAL TECHNOLOGY DEVELOPMENT CO MED ENDAVU: Køb Guangdong True Health Medical Technology Development Co ($2697) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Guangdong True Health Medical Technology Development Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Guangdong True Health Medical Technology Development Co., Ltd. is a China-based medical device company specializing in advanced surgical robotics for minimally invasive oncology care. The company focuses on the research, development, manufacturing, and sale of percutaneous puncture and ablation surgical robots and related equipment used primarily in lung, liver, and abdominal procedures. Its core product line is a family of percutaneous puncture surgical robots designed to assist clinicians in accurately guiding needles through the skin to reach deep or hard-to-access lesions for diagnosis and therapy. Guangdong True Health also offers microwave ablation robots that destroy tumor tissue with heat, cryoablation robots that use controlled freezing, dedicated microwave ablation devices, and ex vivo organ preservation and assessment systems, together with compatible disposables. These solutions position the company as a specialized provider within the healthcare equipment sector, serving hospitals and medical institutions seeking higher precision, consistency, and workflow efficiency in image-guided, minimally invasive cancer treatment. Founded in 2018 and headquartered in Guangdong Province, China, the company operates today as a focused player in percutaneous surgical robotics and related technologies.